Coverage With Evidence Development Study of Percutaneous Image-Guided Lumbar Decompression (PILD) With the Freedom DS Instrument System (FREEDOM-CED)
This study is to satisfy the Centers for Medicare & Medicaid Services (CMS) Coverage with Evidence Development (CED) requirements for percutaneous image-guided lumbar decompression (PILD) procedures for lumbar spinal stenosis (NCD 150.13).
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Echo Director of Clinical Research
- Phone Number: 913-451-4414
- Email: ecundiff@spinalsimplicity.com
Study Contact Backup
- Name: Adam Rogers
- Email: arogers@spinalsimpilicity.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Study population will be representative of the Medicare population eligible for lumbar decompression.
Description
Inclusion Criteria:
-Medicare beneficiaries receiving PILD with FREEDOM DS instruments carrying ICD-10-CM M48.062, spinal stenosis of the lumbar region with neurogenic claudication
Exclusion Criteria:
- Patients that have received PILD, other spinal decompression, or spinal fusion in the lumbar region, in 12 months prior to the index procedure date
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Freedom-DS
All Medicare patients treated with PILD as reported via CPT code 62330. |
PILD is a posterior lumbar decompression performed through a cannula under fluoroscopic guidance. Hypertrophic ligamentum flavum is debulked at the level of stenosis to relieve narrowing of the spinal canal. In this study PILD procedures are performed with the FDA cleared Freedom-DS instruments
Other Names:
|
|
Open Lumbar Decompression
Conventional Open Lumbar Decompression |
Conventional open surgical approach for lumbar decompression including Laminectomy, Facetectomy, and Foraminotomy performed without fusion. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First occurrence of either a procedure-related harm or a subsequent lumbar surgical procedure at any lumbar level
Time Frame: Index procedure through 24 months
|
Index procedure through 24 months
|
|
|
Oswestry Disability Index (ODI)
Time Frame: Index procedure through 12 Months
|
Oswestry Disability Index (ODI) ODI is a self-reported questionnaire widely used to track changes in a patient's condition over time and evaluate the effectiveness of treatments for low back pain. The ODI consists of 10 sections, each addressing a specific aspect of daily functioning. A higher score indicates greater disability. The final score/index ranges from 0-100 scale. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed bound. |
Index procedure through 12 Months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SS-FDS-CED-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All data will be obtained directly from a registry that contains only de-identified data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.